Amyloid light chain (AL) amyloidosis

Clinical trials for Amyloid light chain (AL) amyloidosis explained in plain language.

Never miss a new study

Get alerted when new Amyloid light chain (AL) amyloidosis trials appear

Sign up with your email to follow new studies for Amyloid light chain (AL) amyloidosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy aims to stop rare organ disease

Disease control Recruiting now

This phase 3 trial tests whether adding the experimental drug SCTC21C to standard chemotherapy (bortezomib, cyclophosphamide, dexamethasone) works better than chemo alone for people newly diagnosed with AL amyloidosis. The study will enroll 90 participants and measure how well th…

Matched conditions: AMYLOID LIGHT CHAIN (AL) AMYLOIDOSIS

Phase 3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:02 UTC

Amyloid light chain (AL) amyloidosis

Get alerted when new Amyloid light chain (AL) amyloidosis trials appear

New combo therapy aims to stop rare organ disease